- Home
- CMPX vs VABK Comparison
CMPX vs VABK Comparison
Compare CMPX & VABK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- VABK
- Stock Information
- Founded
- CMPX 2014
- VABK 1998
- Country
- CMPX United States
- VABK United States
- Employees
- CMPX N/A
- VABK N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- VABK Major Banks
- Sector
- CMPX Health Care
- VABK Finance
- Exchange
- CMPX Nasdaq
- VABK Nasdaq
- Market Cap
- CMPX 206.3M
- VABK 211.1M
- IPO Year
- CMPX N/A
- VABK N/A
- Fundamental
- Price
- CMPX $1.46
- VABK $38.54
- Analyst Decision
- CMPX Strong Buy
- VABK
- Analyst Count
- CMPX 4
- VABK 0
- Target Price
- CMPX $13.75
- VABK N/A
- AVG Volume (30 Days)
- CMPX 422.2K
- VABK 7.3K
- Earning Date
- CMPX 11-12-2024
- VABK 01-24-2025
- Dividend Yield
- CMPX N/A
- VABK 3.44%
- EPS Growth
- CMPX N/A
- VABK N/A
- EPS
- CMPX N/A
- VABK 2.89
- Revenue
- CMPX $850,000.00
- VABK $51,571,000.00
- Revenue This Year
- CMPX N/A
- VABK N/A
- Revenue Next Year
- CMPX $610.48
- VABK N/A
- P/E Ratio
- CMPX N/A
- VABK $13.30
- Revenue Growth
- CMPX N/A
- VABK N/A
- 52 Week Low
- CMPX $0.77
- VABK $24.06
- 52 Week High
- CMPX $2.34
- VABK $44.00
- Technical
- Relative Strength Index (RSI)
- CMPX 45.22
- VABK 37.22
- Support Level
- CMPX $1.33
- VABK $37.50
- Resistance Level
- CMPX $1.55
- VABK $42.39
- Average True Range (ATR)
- CMPX 0.12
- VABK 0.96
- MACD
- CMPX -0.00
- VABK -0.40
- Stochastic Oscillator
- CMPX 27.66
- VABK 21.27
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About VABK Virginia National Bankshares Corporation
Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses and charitable organizations.